New monoclonal antibody could be a game-changer in treating rare liver disease by reducing inflammation and fibrosis, says new study – The Times of India

New monoclonal antibody could be a game-changer in treating rare liver disease by reducing inflammation and fibrosis, says new study – The Times of India

A new monoclonal antibody called nebokitug offers fresh hope to patients who have primary sclerosing cholangitis (PSC), because this rare liver disease has limited treatment options until now, except for a transplant. The first set of trials, led by University of California-Davis, US, (Published in the American Journal of Gastroenterology) …

Read more

FDA approves Merck’s drug for rare, deadly lung condition

FDA approves Merck’s drug for rare, deadly lung condition

The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for patients suffering from the rare disease. The agency greenlighted the therapy, which will be marketed as Winrevair, for adults with …

Read more